Study of D-2570 in Subjects With Non-Segmental Vitiligo

NCT07625891 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo
Non-Segmental Vitiligo (NSV)

Interventions

DRUG: D-2570 Dose 1
DRUG: D-2570 Dose 2
DRUG: Placebo
DRUG: D-2570 Dose 3

Sponsor

InventisBio Co., Ltd